Abstract:Introduction: Despite continued improvement in post-sepsis survival, long term morbidity and mortality remain high. Chronic critical illness (CCI), defined as persistent inflammation and organ injury requiring prolonged intensive care, is a harbinger of poor long-term outcomes in sepsis survivors. Current dogma states that sepsis survivors are immunosuppressed, particularly in CCI. Investigation of this immune suppression in heterogeneous immune populations across distinct clinical trajectories and outcomes, along with limited sampling access, is accessible via single-cell RNA sequencing (scRNA-seq). Methods: scRNA-seq analysis was performed on healthy subjects (n=12), acutely septic patients at day 4 ± 1 (n=4), and those defined as rapid recovery (n=4) or CCI (n=5) at day 14-21. Differential gene expression and pathway analyses were performed on peripheral blood lymphocytes at both a population and annotated cell subset level. Cellular function was assessed via enzyme-linked immunosorbent spot (ELISpot), cytokine production analysis, and T-cell proliferation assays on an additional cohort of septic patients (19 healthy, 68 acutely septic, 27 rapid recovery and 20 classified as CCI 14-21 days after sepsis onset). Results: Sepsis survivors that developed CCI exhibited proportional shifts within lymphoid cell populations, with expanded frequency of CD8 + and NK cells. Differential expression and pathway analyses revealed continued activation in T cells and NK cells, with generalized suppression of B-cell function. Both T and NK cell subsets displayed transcriptomic profiles of exhaustion and immunosuppression in CCI, particularly in CD8 + T effector memory (TEM) cells and NK cells. Functional validation of T-cell behavior in an independent cohort demonstrated T cells maintained proliferative responses in vitro yet exhibited a marked loss of cytokine production. IFN-γ production at the acute phase (day 4 ± 1) was significantly reduced in subjects later classified as CCI. Discussion: Sepsis patients exhibit unique T-, B-, and NK-cell transcriptional patterns that are both time- and clinical trajectory-dependent. These transcriptomic and pathway differences in sepsis patients that develop CCI are associated with exhaustion in CD8 + TEM cells and NK cells. Understanding the specific immune system patterns of different cell subsets after sepsis at a molecular level will be key to the development of personalized immunotherapy and drug-targeting intervention. Clinical trial registration: https://clinicaltrials.gov/, identifier NCT02276417.

Identification of a sub-group of critically ill patients with high risk of intensive care unit-acquired infections and poor clinical course using a transcriptomic score

Use of Immune Profiling Panel to assess the immune response of septic patients for prediction of worsening as a composite endpoint

Fully Vertical GaN p-i-n Diodes Using GaN-on-Si Epilayers

A Signature of Immune-Related Genes Correlating with Clinical Prognosis and Immune Microenvironment in Sepsis

Deciphering heterogeneity of septic shock patients using immune functional assays: a proof of concept study

Classification of Patients With Sepsis According to Immune Cell Characteristics: A Bioinformatic Analysis of Two Cohort Studies

Patient stratification using plasma cytokines and their regulators in sepsis: relationship to outcomes, treatment effect and leucocyte transcriptomic subphenotypes

Predicting sepsis severity at first clinical presentation: The role of endotypes and mechanistic signatures

Integrated clustering of multiple immune marker trajectories reveals different immunotypes in severely injured patients

Deep Learning-Based Clustering Robustly Identified Two Classes of Sepsis with Both Prognostic and Predictive Values

Unique lymphocyte transcriptomic profiles in septic patients with chronic critical illness

Flood risk assessment in Pakistan at 1km grid scale

A Combined Score of Circulating miRNAs Allows Outcome Prediction in Critically Ill Patients

A Transcriptome-Based Risk Model in Sepsis Enables Prognostic Prediction and Drug Repositioning

Vector vaccine overcomes anergy.

Deciphering the immune-metabolic nexus in sepsis: a single-cell sequencing analysis of neutrophil heterogeneity and risk stratification

The 'analysis of gene expression and biomarkers for point-of-care decision support in Sepsis' study; temporal clinical parameter analysis and validation of early diagnostic biomarker signatures for severe inflammation andsepsis-SIRS discrimination

Prognostic and predictive enrichment in sepsis

Identifying septic shock subgroups to tailor fluid strategies through multi-omics integration

Clustering ICU patients with sepsis based on the patterns of their circulating biomarkers: A secondary analysis of the CAPTAIN prospective multicenter cohort study

Reaction of 3-dehydroecdysone with certain n.m.r. solvents.